Investors Hope for More From Takeda Than a Healthy Dividend

The company is in early stages of testing gene and cell therapies they hope will deliver ‘transformative and curative’ treatments Continue reading… …read more

Source:: Yahoo Finance

      

Did you enjoy this article? Join our FREE Newsletter!
I agree to have my personal information transfered to MailChimp ( more information )
Join over 100,000 investors and business leaders worldwide. Get the latest actionable business and investing intelligence before the rest of the crowd.
We hate spam. Your email address will not be sold or shared with anyone else.